Productmckinleymedia2020-12-07T14:13:07-08:00

Library

Biomarker Discovery Solutions for Lymphoma and Multiple Myeloma

Provider FAQs for NeXT Dx™ Test

2020 SITC: Orthogonally and functionally validated algorithm for detec...

2020 SITC: B-cell receptor heavy chain repertoire profiling using an a...

2020 SITC: Profiling tumor circulating cell-free DNA with an enhanced ...

2020 SITC: Precision neoantigen discovery using novel algorithms and e...

2020 AMP: An exome and transcriptome based NeXT Dx™ test enables thera...

2020 EACR Liquid Biopsies: Sensitive detection and monitoring of genet...

NeXT Dx Test Requisition Form

Specimen Return Information Form for NeXT Dx Test

2020 AACR: Enhanced Whole Exome Profiling of Tumor Circulating Cell-Fr...

2020 AACR: Improved Tumor-Only Somatic Variant Calling Using a Gradien...

2020 AACR: A diagnostic platform for precision cancer therapy enabling...

2020 AACR: A Pan-Cancer Characterization of Both the Tumor and Micro E...

2020 AACR: Composite neoantigen score is more strongly associated with...

2020 AACR: Quantification of tumor-infiltrating immune cell population...

2020 AACR: Precision neoantigen discovery using a pan-predictive machi...

2020 AACR: Sensitive HLA loss of heterozygosity detection reveals alle...

2020 ASCO: Validation of an exome and transcriptome based diagnostic p...

Personalis NeXT Dx™ Test Data Sheet

ImmunoID NeXT brochure

Biomarker Discovery Solutions

AMP Webinar: Comprehensive Tumor Characterization Using Augmented NGS

Comprehensive Tumor Characterization for Immuno Oncology, Clinical Tri...

ACE Augmentation Achieves High-Sensitivity for Clinical Applications

AMP Webinar: Achieving High Diagnostic Yield for Clinically Relevant G...

Tumor Characterization Solutions for Clinical Trials, Cancer Research ...

NGS Best Practices for Developing Personalized Neoantigen Vaccines

Labroots: Precision Genomics and Precision Medicine for Immuno Oncolog...

Find the answers to the most complex biological questions, with augmen...

Unlocking the potential of personalized neoantigen vaccines with ACE I...

Understanding the drivers of beneficial patient response with ACE Immu...

Precision Genomics for Precision Medicine: Examples in Immuno-Oncology

2016 CIMT: Validation of a Clinical 1400-Gene Assay for Genomic Profil...

2016 EORTA: Analytical validation of comprehensive assays for genomic ...

2016 ENA: Analytical validation of comprehensive assays for genomic pr...

2016 NSGC: Diagnosis of X-linked intellectual disability in an adult f...

2015 AGBT: An Augmented, Extended Cancer Gene Panel Integrating DNA an...

2015 ACMG: Use of an Augmented Exome for Disorders with High Genetic H...

2015 AACR: Solving Genomic Assay Trade-offs with an Optimized, Extende...

2015 AACR: Integrating RNA/DNA Analysis with a Comprehensive Cancer Pa...

2014 ASHG: Using an Augmented Exome to Improve Diagnostic Yield: Case ...

2014 AMP: The ACE Clinical Exome: An Augmented Exome Providing Accurat...

2014 ACMG: User-Friendly Genomic Results: Leveraging a Novel Approach ...

2014 ACMG: Successes using ACE Exome Sequencing to Identify the Geneti...

2014 ACMG: Exome Sequencing in 20 Probands with Developmental Eye Defe...

2013 NSGC: Disease Diagnosis by Exome Sequencing: Issues Hampering Cau...

2013 ASHG: The Genetic Landscape of Moyamoya Disease in a Multi-Ethnic...

2013 ASHG: Recognition of disease-associated alleles in the reference ...